1.4.2026 08:00:00 CEST | Thor Medical ASA | Additional regulated information required to be disclosed under the laws of a member state

Notice is given that the Annual General Meeting of Thor Medical ASA will be held on 23 April 2026, at 14:00 hours CEST at Advokatfirmaet Selmer, Ruseløkkveien 14, 0251 Oslo. The full notice and appendices are attached. The notice and the documents to which it refers are also available on www.thormedical.com. 

DISCLOSURE REGULATION 

This information is required to be disclosed under Section 5-12 of the Securities Trading Act. 

For further information please contact:  

Mathias Nilsen Reierth  

Head of Communications and Corporate Affairs 

Tel: +47 988 05 724  

mathias.reierth@thormedical.com

About Thor Medical ASA

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'. 

To learn more, visit www.thormedical.com 

Attachments

• Download announcement as PDF.pdf
• Thor Medical - Proposed resolutions for the AGM 2026 English.pdf
• Thor Medical - Proposed resolutions for the AGM 2026 Norsk.pdf
• Thor Medical - Notice of AGM 2026 English.pdf
• Thor Medical - Notice of AGM 2026 Norsk.pdf